MeiraGTx Holdings plc
- MGTX
- NASDAQ
- Biotechnology
- Gene Therapy
- Clinical-stage Biotech (Ocular)
$9.28
Today −6.17%Quote Oct 16, 2026, 08:00 PM UTC
−28.89%over the last month
Max drawdown −30.0%From 1-month high −30.0%3 months −24.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$891.3M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$21.00
+126.3% from here
Floor
$8.66
6.7% below price
Where the price sits
7 analysts
Analyst range, low to high
$16.00$26.00
- Price $9.28
- Resistance $9.62
- Consensus $21.00
Analysts' average target sits about 126% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MGTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $321.4M
- Related Party Service Revenue$104.9M32.6%
- Service$11.9M3.7%
- Other / not reported$204.6M63.7%
Industry
Biotechnology
Employees
393